7-肼基-5-甲基-3-苯基吡唑并[1,5-a]嘧啶
|
H346934-1g
|
|
58347-29-8 |
1g
|
¥ 2651.9
|
期货,请咨询 |
阿拉丁 |
7-肼基-5-甲基-3-苯基吡唑并[1,5-a]嘧啶
|
H346934-250mg
|
|
58347-29-8 |
250mg
|
¥ 1312.9
|
期货,请咨询 |
阿拉丁 |
4-羟基壬烯醛-d3
|
H346904-500μg
|
A solution in methyl acetate |
148706-06-3 |
500μg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
4-羟基壬烯醛-d3
|
H346904-100μg
|
A solution in methyl acetate |
148706-06-3 |
100μg
|
¥ 2499.9
|
期货,请咨询 |
阿拉丁 |
4-羟基壬烯醛-d3
|
H346904-50μg
|
A solution in methyl acetate |
148706-06-3 |
50μg
|
¥ 1399.9
|
期货,请咨询 |
阿拉丁 |
5-[(1H-吡咯-2-基)甲基]-1H-吡咯-2-甲醛
|
H346723-500mg
|
|
36746-27-7 |
500mg
|
¥ 3430.9
|
期货,请咨询 |
阿拉丁 |
5-[(1H-吡咯-2-基)甲基]-1H-吡咯-2-甲醛
|
H346723-250mg
|
|
36746-27-7 |
250mg
|
¥ 2065.9
|
期货,请咨询 |
阿拉丁 |
Herboxidiene
|
H346616-1mg
|
|
142861-00-5 |
1mg
|
¥ 7036.9
|
期货,请咨询 |
阿拉丁 |
7-羟基格拉司琼-d3盐酸盐
|
H346615-0.5mg
|
|
2124272-03-1 |
0.5mg
|
¥ 2092.9
|
期货,请咨询 |
阿拉丁 |
亚硫酸氢离子载体I
|
H346575-250mg
|
|
151029-29-7 |
250mg
|
¥ 4686.9
|
期货,请咨询 |
阿拉丁 |
3-(2-羟乙基)-1,2,3,4-四氢喹唑啉-2,4-二酮
|
H346548-1g
|
|
1207-75-6 |
1g
|
¥ 2783.9
|
期货,请咨询 |
阿拉丁 |
3-(2-羟乙基)-1,2,3,4-四氢喹唑啉-2,4-二酮
|
H346548-250mg
|
|
1207-75-6 |
250mg
|
¥ 1375.9
|
期货,请咨询 |
阿拉丁 |
2-十六醇
|
H346541-1g
|
≥95% |
14852-31-4 |
1g
|
¥ 1029.9
|
现货 |
阿拉丁 |
11-二十一醇
|
H346517-1g
|
≥97% |
3381-26-8 |
1g
|
¥ 142.9
|
现货 |
阿拉丁 |
4'-羟基联苯-2-羧酸
|
H346489-1g
|
|
67526-82-3 |
1g
|
¥ 3116.9
|
期货,请咨询 |
阿拉丁 |
1,2,3,4,7,8-六氯二苯并二恶英
|
H346482-5mg
|
|
39227-28-6 |
5mg
|
¥ 1953.9
|
期货,请咨询 |
阿拉丁 |
1,2,3,7,8,9-六氯二苯并二恶英
|
H346479-10mg
|
|
19408-74-3 |
10mg
|
¥ 16399.9
|
期货,请咨询 |
阿拉丁 |
1,2,3,7,8,9-六氯二苯并二恶英
|
H346479-1mg
|
|
19408-74-3 |
1mg
|
¥ 1953.9
|
期货,请咨询 |
阿拉丁 |
[4-(1H-吡唑-1-基)苯基]乙酸
|
H346468-1g
|
|
65476-24-6 |
1g
|
¥ 2783.9
|
期货,请咨询 |
阿拉丁 |
[4-(1H-吡唑-1-基)苯基]乙酸
|
H346468-250mg
|
|
65476-24-6 |
250mg
|
¥ 1375.9
|
期货,请咨询 |
阿拉丁 |
七氟丁酰脒
|
H346461-5g
|
≥97% |
375-19-9 |
5g
|
¥ 2999.9
|
现货 |
阿拉丁 |
七氟丁酰脒
|
H346461-1g
|
≥97% |
375-19-9 |
1g
|
¥ 999.9
|
现货 |
阿拉丁 |
六氟异丙基三氟乙酸盐
|
H346459-25g
|
|
42031-15-2 |
25g
|
¥ 823.9
|
期货,请咨询 |
阿拉丁 |
独活素
|
H346328-5mg
|
≥98% |
2880-49-1 |
5mg
|
¥ 689.9
|
现货 |
阿拉丁 |